STUDIES OF BENZ(A)ANTHRAQUINONE ANTIBIOTICS
STUDIES OF BENZ(A)ANTHRAQUINONE ANTIBIOTICS
批准号:
2684753
负责人:
PHILIP J. PROTEAU
金额:
$21.58万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
1982
资助国家:
美国
项目状态:
已结题
起止时间:
1982-12-01 至 1999-09-30
中文摘要
点击翻译按钮获取中文摘要
英文摘要
The specific aims of this program focus on benz[a]anthraquinone-
derived antibiotics. Work will be continued on the kinamycin
antibiotics produced by Streptomyces murayamaensis, and on
antibiotic PD 116740, produced by S. WP 4669. A limited set of
experiments will be carried out in S. rimosus, in order to identify
one of the key branch-points in the general matrix of
benz[a]anthraquinone biosynthesis by examining the
precursor/product relationship of tetrangomycin and tetrangulol.
The Research Design includes structural studies to identify more
biosynthetic intermediates in each pathway. This will be done by a
combination of characterizing additional metabolites, and of
synthesizing and testing reasonable candidates. In the kinamycin
pathway, metabolites that are potentially intermediates will be
identified by feeding known intermediates to a current set of 37
blocked mutants. The Research Design will include biochemical
studies to detect and characterize key enzymes in these pathways
(e.g. for amino- and amidotransferases, aryl epoxidases and
arylepoxide hydrolases, hydroquinone epoxidases, and aromatic
ringcleaving enzymes), and molecular genetics studies to clone,
sequence, and characterize selected genes.
The broad objective of this research program is to understand which
chemical reactions are available in Nature and how they are linked
together to produce complex structures with significant bio-
medically relevant activity, in particular, antibiosis. This
objective will be attained through the described multi-faceted
approach that blends carefully chosen experiments in synthesis,
biosynthesis, enzymology and molecular genetics. Such an
interdisciplinary approach has become more and more essential for
the modern bioorganic chemist who desires to study metabolism, its
regulation and its consequences. It will lay the groundwork for
applications such as modifying bioactivity by metabolic and genetic
engineering to generate new molecular structures. This
interdisciplinary approach is also an effective vehicle to train
new chemists with an understanding of biology and a broad range of
skills for solving important biochemical problems.
期刊论文(5)
专著(0)
科研奖励(0)
会议论文
Kinamycin acetyltransferase I from Streptomyces murayamaensis, an apparently large, membrane-associated enzyme.
来自村山链霉菌的动霉素乙酰转移酶 I,一种明显较大的膜相关酶。
DOI:
10.1016/0968-0896(96)00097-1
发表时间:
1996
期刊:
Bioorganic & medicinal chemistry
影响因子:
3.5
作者:
[Gould,SJ, O'Hare,T, Seaton,P, Soodsma,J, Tang,Z]
通讯作者:
Tang,Z
DOI:
10.7164/antibiotics.42.189
发表时间:
1989-02
期刊:
The Journal of antibiotics
影响因子:
--
作者:
[P. Seaton;S. Gould]
通讯作者:
P. Seaton;S. Gould
DOI:
10.1021/np50107a005
发表时间:
1994-05
期刊:
Journal of natural products
影响因子:
5.1
作者:
[C. Melville;S. Gould]
通讯作者:
C. Melville;S. Gould
Pleuromutilin Biosynthetic Studies
-
批准号:8073650
-
项目类别:
-
资助金额:$18.09万
-
财政年份:2010
-
负责人:PHILIP J. PROTEAU
-
依托单位:
Pleuromutilin Biosynthetic Studies
-
批准号:7881349
-
项目类别:
-
资助金额:$21.93万
-
财政年份:2010
-
负责人:PHILIP J. PROTEAU
-
依托单位:
ISOPRENOID BIOSYNTHESIS: NON-MEVALONATE PATHWAY STUDIES
-
批准号:6631995
-
项目类别:
-
资助金额:$19.39万
-
财政年份:2000
-
负责人:PHILIP J. PROTEAU
-
依托单位:
ISOPRENOID BIOSYNTHESIS: NON-MEVALONATE PATHWAY STUDIES
-
批准号:6362343
-
项目类别:
-
资助金额:$18.28万
-
财政年份:2000
-
负责人:PHILIP J. PROTEAU
-
依托单位:
ISOPRENOID BIOSYNTHESIS: NON-MEVALONATE PATHWAY STUDIES
-
批准号:6510784
-
项目类别:
-
资助金额:$18.82万
-
财政年份:2000
-
负责人:PHILIP J. PROTEAU
-
依托单位:
ISOPRENOID BIOSYNTHESIS: NON-MEVALONATE PATHWAY STUDIES
-
批准号:6043155
-
项目类别:
-
资助金额:$19.49万
-
财政年份:2000
-
负责人:PHILIP J. PROTEAU
-
依托单位:
FARNESYL DIPHOSPHATE SYNTHASE--CATALYTIC SITE STUDIES
-
批准号:2171440
-
项目类别:
-
资助金额:$0.68万
-
财政年份:1995
-
负责人:PHILIP J. PROTEAU
-
依托单位:
FARNESYL DIPHOSPHATE SYNTHASE--CATALYTIC SITE STUDIES
-
批准号:2171439
-
项目类别:
-
资助金额:$2.37万
-
财政年份:1994
-
负责人:PHILIP J. PROTEAU
-
依托单位:
海外基金